Antibody Cocktails Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027
Report Description
The global Antibody Cocktails market size is estimated at USD XX million in 2020, expanding at a CAGR of 6.8% from 2021 to 2027 to reach XX Million USD in 2027.
Market Dynamics
An antibody, also known as immunoglobulin, is a protective protein produced by the body's immune system in response to the presence of a foreign substance known as an antigen. Antigens are a diverse group of substances that include pathogenic organisms as well as toxic materials such as insect venom, bacteria, or viruses. An antibody cocktail is a mixture or cocktail of two different antibodies. The rationale for combining two antibodies in a cocktail approach is to reduce viral mutational escape.
The increasing use of inorganic strategies such as partnerships and agreements by key market players is expected to drive market growth during the forecast period. For example, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, formed a strategic partnership under which F. Hoffmann-La Roche Ltd. will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will be marketed and distributed through Cipla's distribution network.
Regional Insights
The antibody cocktails market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest share of the custom antibody market in 2020. This region's large share can be attributed to rising investments in the development of structure-based drug designs, expanding research in genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and a growing emphasis on developing antibody-based therapeutics. Another important factor contributing to this market segment's large share is the presence of a large number of global players in this region.
Segment Insights
The Antibody Cocktails market is fragmented into type, indication and distribution channel segments. Based on the type, the monovalent are anticipated to dominate the market. Based on the indication, the COVID-19 indication showcased the highest CAGR in the forecast period. By distribution channel, online pharmacies showcased highest CAGR.
Competitive Insights
Key companies in the Antibody Cocktails Market include Cipla Inc., Hoffmann, La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc. and Eli Lilly and Company. For example, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, formed a strategic partnership under which F. Hoffmann-La Roche Ltd. will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will be marketed and distributed through Cipla's distribution network.
The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses market size and forecast of Antibody Cocktails by type, indication, distribution and region. In addition, this report introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
- Cipla
- Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc.
- Zydus Cadila
- AstraZeneca
- Aridis Pharmaceuticals Inc.
- AstraZene Immunome Inc.
- Celltrion Healthcare Co., Ltd.
- Eli Lilly and Company
Type Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Monovalent antibody
- Polyvalent antibody
Indication Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- COVID-19
- Cancer
- HIV
- Others
Distribution Channel Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)
Table Of Content
1. Antibody Cocktails Market Overview
1.1. Product Overview and Scope of Antibody Cocktails
1.2. Global Market Growth Prospects and Revenue Estimates
1.3. Global Antibody Cocktails Market Size Growth Rate Analysis by Type 2020 VS 2027
1.3.1. Monovalent antibody
1.3.2. Polyvalent antibody
1.4. Global Antibody Cocktails Comparison by Indication: 2020 VS 2027
1.4.1. COVID-19
1.4.2. Cancer
1.4.3. HIV
1.4.4. Others
1.5. Global Antibody Cocktails Comparison by Distribution Channel: 2020 VS 2027
1.5.1. Hospital Pharmacies
1.5.2. Retail Pharmacies
1.5.3. Online Pharmacies
1.6. Global Antibody Cocktails Market Size Estimates and Forecasts by Region: 2020 VS 2027
1.6.1. North America Antibody Cocktails Estimates
1.6.2. Europe Antibody Cocktails Estimates
1.6.3. Asia Pacific Antibody Cocktails Estimates
1.6.4. South America Antibody Cocktails Estimates
1.6.5. Middle East & Africa Antibody Cocktails Estimates
2. Market Competition by Manufacturers
2.1. Global Antibody Cocktails Revenue Market Share by Manufacturers (2020)
2.2. Antibody Cocktails Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3. Global Antibody Cocktails Average Price by Manufacturers (2020-2027)
2.4. Manufacturers Antibody Cocktails Production Sites, Area Served, Product Types
2.5. Antibody Cocktails Market Competitive Situation and Trends
2.5.1. Antibody Cocktails Market Concentration Rate
2.5.2. Mergers & Acquisitions, Expansion
3. Global Antibody Cocktails Consumption by Region (2020-2027)
3.1. Global Antibody Cocktails Consumption by Region
3.2. Global Antibody Cocktails Consumption Market Share by Region
3.2.1. North America
3.2.2. North America Antibody Cocktails Consumption Growth Rate (2020-2027)
3.2.3. North America Antibody Cocktails Consumption, Price and Gross Margin (2020-2027)
3.2.4. North America Antibody Cocktails Consumption by Country
3.2.4.1. U.S.
3.2.4.2. Canada
3.2.5. Europe
3.2.6. Europe Antibody Cocktails Consumption Growth Rate (2020-2027)
3.2.7. Europe Antibody Cocktails Consumption, Price and Gross Margin (2020-2027)
3.2.8. Europe Antibody Cocktails Consumption by Country
3.2.8.1. Germany
3.2.8.2. U.K.
3.2.8.3. France
3.2.8.4. Italy
3.2.8.5. Spain
3.2.9. Asia Pacific
3.2.10. Asia Pacific Antibody Cocktails Consumption Growth Rate (2020-2027)
3.2.11. Asia Pacific Antibody Cocktails Consumption, Price and Gross Margin (2020-2027)
3.2.12. Asia Pacific Antibody Cocktails Consumption by Country
3.2.12.1. China
3.2.12.2. India
3.2.12.3. Japan
3.2.12.4. Indonesia
3.2.12.5. Malaysia
3.2.12.6. Australia
3.2.12.7. South Korea
3.2.13. South America
3.2.14. South America Antibody Cocktails Consumption Growth Rate (2020-2027)
3.2.15. South America Antibody Cocktails Consumption, Price and Gross Margin (2020-2027)
3.2.16. South America Antibody Cocktails Consumption by Country
3.2.16.1. Brazil
3.2.16.2. Mexico
3.2.16.3. Argentina
3.2.17. Middle East and Africa
3.2.18. Middle East and Africa Antibody Cocktails Consumption Growth Rate (2020-2027)
3.2.19. Middle East and Africa Antibody Cocktails Consumption, Price and Gross Margin (2020-2027)
3.2.20. Middle East and Africa Antibody Cocktails Consumption by Country
3.2.20.1. Saudi Arabia
3.2.20.2. Kuwait
3.2.20.3. UAE
3.2.20.4. South Africa
4. Global Antibody Cocktails Consumption by Type (2020-2027)
4.1. Global Antibody Cocktails Price by Type (2020-2027)
4.2. Global Antibody Cocktails Revenue Market Share by Type (2020-2027)
4.2.1. Monovalent antibody
4.2.2. Polyvalent antibody
5. Global Antibody Cocktails by Material Indication (2020-2027)
5.1. Global Antibody Cocktails Price by Material Indication (2020-2027)
5.2. Global Antibody Cocktails Revenue Market Share by Material Indication (2020-2027)
5.2.1. COVID-19
5.2.2. Cancer
5.2.3. HIV
5.2.4. Others
6. Global Antibody Cocktails Consumption by Distribution Channel (2020-2027)
6.1. Global Antibody Cocktails Price by Distribution Channel (2020-2027)
6.2. Global Antibody Cocktails Revenue Market Share by Distribution Channel (2020-2027)
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
7. Key Companies Profiled
7.1. Cipla
7.1.1. Cipla Antibody Cocktails Corporation Information
7.1.2. Cipla Antibody Cocktails Product Portfolio
7.1.3. Cipla Antibody Cocktails Consumption, Price and Gross Margin (2020-2027)
7.1.4. Cipla Main Business and Markets Served
7.1.5. Cipla Recent Developments/Updates
7.2. F. Hoffmann-La Roche Ltd
7.3. Regeneron Pharmaceuticals Inc.
7.4. Zydus Cadila
7.5. AstraZeneca
7.6. Aridis Pharmaceuticals Inc.
7.7. AstraZene Immunome Inc.
7.8. Celltrion Healthcare Co., Ltd.
7.9. Eli Lilly and Company
8. Marketing Channel, Distributors and Customers
8.1. Marketing Channel
8.2. Antibody Cocktails Distributors List
8.3. Antibody Cocktails Customers
9. Market Dynamics
9.1. Antibody Cocktails Industry Trends
9.2. Antibody Cocktails Growth Drivers
9.3. Antibody Cocktails Market Challenges
9.4. Antibody Cocktails Market Restraints
10. Global Antibody Cocktails Consumption and Demand Forecast, by region (2022-2027)
10.1. Global Forecasted Demand Analysis of Antibody Cokatails, by Regions and Country
10.1.1. North America Forecasted Consumption of Antibody Cocktails by Country
10.1.2. Europe Market Forecasted Consumption of Antibody Cocktails by Country
10.1.3. Asia Pacific Market Forecasted Consumption of Antibody Cocktails by Region
10.1.4. Latin America Forecasted Consumption of Antibody Cocktails by Country
10.1.5. Middle East and Africa Forecasted Consumption of Antibody Cocktails by Country
11. Research Finding and Conclusion
12. Methodology and Data Source
12.1. Methodology/Research Approach
12.1.1. Research Programs/Type
12.1.2. Market Size Estimation
12.1.3. Market Breakdown and Data Triangulation
12.2. Data Source
12.2.1. Secondary Sources
12.2.2. Primary Sources
12.3. Author List
12.4. Disclaimer
Research Methodology
Our research studies are primarily performed in five phases which include Secondary Research, Primary Research, Subject Matter Expert Advice, Quality Check, and Final Review. The process opted for conducting thorough research to make authentic business reports is briefly described below-
Secondary Research-
- Based on the understanding of requirements, we conducted secondary research to identify the Segment specifications, qualitative and quantitative data along with the factors responsible for the growth of the market.
- The secondary sources referred for the study include press releases, company annual reports, and research papers related to the industry.
- Various sources such as industry magazines, trade journals, government websites, and associations were also reviewed for gathering precise analysis on opportunities for business expansions in the market.
- Moreover, quantitative as well as qualitative data were also extracted from paid databases, which included Reuters, Factiva, Bloomberg, One Source, and Hoovers, which proved to be useful for in-depth technical study of the market.
Primary Research-
- The research carried out during the desk research was verified by primary interviews. Primary research was scheduled with a number of industry experts for conducting telephonic interviews, and also our team send questionnaires through their official emails.
- The secondary data collected was then verified by various industry participants which included Segment managers, marketing managers, VPs, CEOs, purchasing managers, subject matter experts.
- An interview with the mentioned participants aids invalidation of our research findings regarding the Segment.
- It helps in the provision of first-hand data on factors such as market size, growth, regional trends, market trends, and competition in the industry. This approach makes our findings precise in order to help our clients in strategic decision-making processes.
Subject Matter Advice-
- The secondary and primary research key findings were then validated by the in-house subject matter experts having extensive experience in the market research industry.
- Specific requirements of the clients were reviewed by the experts to check for completion of the market study. Experts help in channelizing the representation skills of the analyst in terms of providing data that can be easily understood by our customers.
Quality Check-
- The analysis done by the research team was further reviewed to check for data accuracy provided to suit the clients’ specific requirements.
- This revision was done in various phases to check the data authenticity and to remove negligible errors in the final compilation.
Final Review-
- After the quality check, a final review of the report was done to look after the presentation, formatting, and to recheck if all the requirements of the clients were addressed. The next phase remains dispatch of the report to the client.
Enquire Before Purchase
Frequently Asked Questions
Why Choose Market Research Strategy?
We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports
We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround
Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.
We abide by the information security policy and adheres to keep your private and business information confidential and secure.